News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Savill Corrine
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/21/2023 |
4
| Savill Corrine (Chief Business Officer) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Granted 20,500 shares
@ $0
Granted 41,000 options to buy
@ $11.34, valued at
$464.9k
|
|
| 07/21/2022 |
4
| Savill Corrine (Acting Chief Business Officer) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 5,042 shares
@ $15.06, valued at
$75.9k
Sold 14,958 shares
@ $15.22, valued at
$227.7k
|
|
| 07/12/2022 |
4
| Savill Corrine (Acting Chief Business Officer) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 39,800 shares
@ $13.33, valued at
$530.5k
Sold 200 shares
@ $13.85, valued at
$2.8k
|
|
| 02/15/2022 |
4
| Savill Corrine (Acting Chief Business Officer) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Granted 16,500 shares
@ $0
Granted 33,000 options to buy
@ $13.6, valued at
$448.8k
|
|
| 01/07/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|